Associated Papers
Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer.
Tsoi H et al.
Journal of Translational Medicine, 2025
40764992 (PubMed )
Supplement: 12967_2025_6902_MOESM4_ESM.xlsx › Sheet1
Select a paper to view details